Rosetta Genomics' microRNA-Based Assay For Thyroid Cancer Highlighted In Poster Presentation At 84th Annual Meeting Of The American Thyroid Association
October 23, 2014 at 08:06 AM EDT
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that data in ...